PharmEasy: A difficult prognosis
Parent API Holdings seems to be banking on FOMO to raise public money at 500% more than what it was valued at nine months ago.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Internet
You may also like
How Kerala brought its infant mortality rate to a historic low
Decades of investment in health and social infrastructure went into getting the southern state’s infant mortality rate down to 5 deaths per 1,000 live births—far lower than the national average of 25.
The growing unease of EaseMyTrip’s investors
The online travel aggregator is struggling to grow now more than ever. Meanwhile, its promoters' stake sales reveal a pump and dump pattern that does little to ease shareholders’ concerns.
Lenskart may be the redemption Indian new-age businesses need
The 17-year-old eyewear company is finally approaching the public markets. Its stellar numbers and international footprint set it apart.
